Published in EMBO Rep on May 30, 2014
Ubiquitin modifications. Cell Res (2016) 1.10
USP18 lack in microglia causes destructive interferonopathy of the mouse brain. EMBO J (2015) 1.05
Linear ubiquitination in immunity. Immunol Rev (2015) 0.98
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ (2016) 0.98
Molecular crosstalk between apoptosis, necroptosis, and survival signaling. Mol Cell Oncol (2015) 0.91
Vitamin E γ-Tocotrienol Inhibits Cytokine-Stimulated NF-κB Activation by Induction of Anti-Inflammatory A20 via Stress Adaptive Response Due to Modulation of Sphingolipids. J Immunol (2015) 0.83
Regulation of Met1-linked polyubiquitin signalling by the deubiquitinase OTULIN. FEBS J (2015) 0.79
More to Life than NF-κB in TNFR1 Signaling. Trends Immunol (2016) 0.79
Poly-ubiquitination in TNFR1-mediated necroptosis. Cell Mol Life Sci (2016) 0.78
A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator. Arthritis Res Ther (2016) 0.78
TCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complex. Mol Immunol (2015) 0.77
NF-κB in inflammation and renal diseases. Cell Biosci (2015) 0.77
Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome. Nat Immunol (2017) 0.76
Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of β-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor κB (NFκB) Activation. J Biol Chem (2016) 0.76
The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes. EMBO Rep (2016) 0.76
Deconstructing innate immune signaling in myelodysplastic syndromes. Exp Hematol (2015) 0.76
Ubiquitylation as a Rheostat for TCR Signaling: From Targeted Approaches Toward Global Profiling. Front Immunol (2015) 0.75
A20: attractive without showing cleavage. EMBO Rep (2014) 0.75
Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence. Nat Commun (2017) 0.75
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature (2004) 12.41
Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science (2000) 10.98
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol (2004) 9.42
NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev (2012) 5.77
Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell (2009) 5.44
The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci U S A (1996) 4.03
Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science (2010) 4.03
Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat Rev Immunol (2008) 2.98
The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem (1992) 2.90
Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20. J Exp Med (2008) 2.80
A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat Rev Immunol (2012) 2.47
A20 zinc finger protein inhibits TNF and IL-1 signaling. J Immunol (1996) 2.44
Direct, noncatalytic mechanism of IKK inhibition by A20. Mol Cell (2011) 2.32
Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem J (2004) 2.23
The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity (2010) 1.97
Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem J (2008) 1.94
Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20. J Mol Biol (2007) 1.82
A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol Cell Biol (2002) 1.77
IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response. Nature (2010) 1.68
African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity. J Immunol (2010) 1.52
A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7. EMBO J (2012) 1.45
Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling. Mol Cell (2010) 1.41
Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation. EMBO J (2012) 1.39
Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme. Immunity (2013) 1.13
Localization of A20 to a lysosome-associated compartment and its role in NFkappaB signaling. Biochim Biophys Acta (2008) 1.11